The rating reflects Moody’s expectation that Erlanger will translate market share growth and strong top-line revenue into improved financial performance.
The rating outlook has been revised from positive to stable.
More articles on healthcare finance:
Financial troubles force Texas health system to shut down
Cleveland Clinic’s operating income jumps 76% in Q3
12 health systems with strong finances
